Seller template code Unipure Biotech - Pharma Franchise Company & Pharma Manufacturing Company from Chandigarh, India

Welcome To Unipure Biotech

Nature of Business

Pharma Franchise Company & Pharma Manufacturing Company

Ownership Type

Private Limited Company

Company CEO

Rajinder Singh Rana

Registered Address

SCF-230, 1st & 2nd Floor, Motor Market, Manimajra, Chandigarh 160101

Total Number of Employees

11 to 25 People

Annual Turnover

Rs. 10 - 25 Crore

We have made full-size strides to end up a leading pharmaceutical organization in India through product diversification, increasing production capacities, and launching new business employer possibilities. By constantly seizing opportunities, we've got

Why Us

We are prominent in the market due to our ability to provide quality approved range at reasonable costs. Moreover, we are repeatedly getting orders from clients and it is just because of our expertise and ability to provide highly effective medicines.Our key strengths are:Quality approved a range of medicinesHigh-tech processing unitEthical business policiesTransparent dealingsHuge distribution networkMarket leading prices

Vision and Mission

To provide affordable drugs for essential therapies. To continue to have the 1st mover advantage in the domestic market in various therapeutic segments To be a strong vertically integrated global generic manufacturer.Our vision is to become a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs.Our goal is to provide the best quality early-stage clinical development services to an international customer base of generic, biotechnology and pharmaceutical companies with a focus on customer service. We will achieve this by continuously looking for ways to improve our customer relationships and range of services and by creating an environment that provides value for our customers, respect for our participants, returns for our shareholders and growth for our employees.